References
- Kim SH, Chung HC, Jeong J, Kim JH, Rha SY, Ahn JB, et al. A locally advanced breast cancer with difficult differential diagnosis of carcinosarcoma and atypical medullary carcinoma, which had poor response to adriamycin- and taxane-based neoadjuvant chemotherapy. Cancer Res Treat 2007; 39:134–7.
- Gutman H, Pollock RE, Janjan NA, Johnson DA. Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg 1995; 180:193–199.
- Foschini MP, Dina RE, Eusebi V. Sarcomatoid neoplasms of the breast: Proposed definitions for biphasic and monophasic sarcomatoid mammary carcinomas. Semin Diagn Pathol 1993; 10:128–136.
- Rosai J. Special techniques in surgical pathology. Rosai and Ackerman's Surgical Pathology, Mosby Ninth edition. 2004; 1810–1812.
- Tseng WH, Martinez SR. Metaplastic breast cancer: to radiate or not to radiate? Ann Surg Oncol 2011; 18:94–103.
- Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer 1989; 64:1490–9.
- Harris M, Persaud V. Carcinosarcoma of the breast. J Pathol 1974; 112:99–105.
- Tampaki EC, Tampakis A, Agrogiannis G, Kavantzas N, Kontzoglou K, Kouraklis G. A Case of Positive Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma (Carcinosarcoma). Towards Novel Therapeutic Targets. Case Report Onkologie 2013; 36:506–509.
- WHO Classification of Tumors Editorial Board, ed. WHO classification of tumors, 5th edition – Breast tumors. Lyon: International Agency for Research on Cancer 2019.
- Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2:442–54.
- Azzopardi JG. Problems in breast pathology. Philadelphia: WB Saunders 1979; 373–378.
- Esses KM, Hagmaier RM, Blanchard SA, Lazarchick JJ, Riker AI. Carcinosarcoma of the breast: two case reports and review of the literature. Cases Journal 2009; 2:15.
- Atahan K, Gur S, Tarcan E. Carcinosarcoma of the breast. J Breast Health 2007; 3:85–6.
- Abbasi MA, Mahmood H, Faheem M, Khan KA and Irfan J. Carcinosarcoma of the Breast. J Coll Physicians Surg Pak 2012; 22:333–334.
- Takudome N, Sakamoto G, Sakai T, Sarumaru S, Okuyama N, Hori F et al. A Case of Carcinosarcoma of the Breast. Breast Cancer 2005; 12:149–153.
- Koufopoulos N, Kokkali S, Antoniadou F, Dimas D, Missitzis I. Matrix-producing Breast carcinoma: A Rare Subtype of Metaplastic Breast Carcinoma. Cureus. 2019 Jul 22; 11(7):e5188.
- Koufopoulos N, Kokkali S, Antoniadou F, et al. EP213 Undifferentiated pleomorphic sarcoma of the breast: presentation of a case. International Journal of Gynecologic Cancer 2019; 29:A182–A183.
- Duran-Moreno J, Kokkali S, Ramfidis V, et al. Primary Sarcoma of the Lung Prognostic Value of Clinicopathological Characteristics of 26 Cases. Anticancer Res. 2020; 40(3):1697–1703
- Bajpai J, Punatar SB, Gupta A, Badwe R, Gupta S. Bilateral adenomyoepithelioma of breast. J Cancer Res Ther. 2013; 9(3):523–5.
- Tse GM, Tan PH, Putti TC, Lui PC, Chaiwun B, Law BK. Metaplastic carcinoma of the breast: a clinicopathologic review. J Clin Pathol 2006; 59:1079–83.
- Chao TC, Wang CS, Chen SC, et al. Metaplastic carcinomas of the breast. J Surg Oncol 1999; 71:220–5.
- Rayson D, Adjei AA, Suman VJ, et al. Metaplastic breast cancer: prognosis and response to systemic therapy. Ann Oncol 1999; 10:413–9.
- Kim SH, Chung HC, Jeong J, Kim JH, Rha SY, Ahn JB, et al. A locally advanced breast cancer with difficult differential diagnosis of carcinosarcoma and atypical medullary carcinoma, which had poor response to adriamycin- and taxane-based neoadjuvant chemotherapy. Cancer Res Treat 2007; 39:134–7.
- Al Sayed AD, El Weshi AN, Tulbah AM, Rahal MM, Ezzat AA. Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors. Acta Oncol 2006; 45: 188–95.
- Tse GM, Tan PH, Putti TC, Lui PC, Chaiwun B, Law BK. Metaplastic carcinoma of the breast: a clinicopathological review. J Clin Pathol 2006; 59:1079–83.
- Sneige N, Yaziji H, Mandavilli SR, Perez ER, Ordonez NG, Gown AM, Ayala A. Low-grade (fibromatosis-like) spindle cell carcinoma of the breast. Am J Surg Pathol 2001; 25:1009–16.
- Shah DR, Tseng WH, Martinez SR. Treatment options for metaplastic breast cancer. ISRN Oncol 2012; 2012:706162.
- Leibl S, Moinfar F. Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors. J Clin Pathol 2005; 7:700–4.